Management Team

Remi Gloeckler

PhD, CMC Advisor

CMC Advisor, Remi Gloeckler, has extensive experience from CMC and Quality Assurance of viral vectors. He has worked for decades in leadership positions at Transgene, and is the founder of Pharmincell. Remi participated in development of several clinical stage drug candidates. He has been supporting TILT’s CMC and development since 2016.

Akseli Hemminki

MD, PhD, eMBA, Founder & CEO and Member of the Board of Directors

Aino Kalervo

MSc, MS, Chief Operating Officer

Kari Varkila

MD, PhD, MBA, Chief Medical Officer

Tuija Keinonen

PhD, Prof, Chief Regulatory Officer, Chair of the Board of Directors

Juha Pihlman

BSc, CFO consultant

Suvi Sorsa

PhD, VP of Clinical Affairs

Víctor Cervera-Carrascón

PhD, VP of Business Development

Hanna Kirk

MSc, VP of Product Development

Riikka Havunen

PhD, VP of Operations

John Goldfinch

MBA, CRM, US Clinical Lead

Elina Haavisto

MSc, Head of CMC Regulatory Affairs

Claudia Kistler

PhD, Head of Clinical Operations

João Manuel Santos

PhD, Head of Translational Medicine

Henrik Roosvall

BSc, Business Operations Manager

James Clubb

MSc, Project Manager

Dafne Quixabeira

PhD, Project Manager

Katja Saarikko

Operations Coordinator

Sini Raatikainen

MSc, Lab Manager

Sanae Zahraoui

Supply Chain Manager

Lyna Haybout

MD, Medical Monitor

Minna Oksanen

MSc, Office Manager